Some antigens of CTAs family have also been proved to be novel biomarkers for various types of malignancies, such as MAGE-1 for differentiated advanced gastric cancer [8], LY6K for bladder cancer [26], and sperm protein 17 for cervical cancer [27]. This evidence concerns the gene LY6K and cervical carcinoma.